#YonhapInfomax #SamsungBiologics #OperatingProfit #FirstQuarter #YearOverYearGrowth #ContractManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=116888

SK Bioscience strengthens production cooperation with subsidiary IDT Biologika for second-generation Zaire Ebola vaccine development with MSD, expanding its global vaccine production network to address infectious disease outbreaks in Africa including Democratic Republic of Congo.

Samsung Biologics CEO John Rim, reappointed for a third term, pledges to accelerate expansion in production capacity, portfolio diversification, and global presence despite challenging market conditions, while advancing U.S. plant acquisition and domestic bio campus construction.
Contract Manufacturing in the Pharmaceutical Industry
Contract manufacturing has become a strategic growth model for pharmaceutical companies facing rising costs, complex regulations, and faster time-to-market demands. This article explores how Indian pharma manufacturers support global healthcare supply chains through quality, compliance, and scalability.
🔗 Read more: [https://kilitchhealthcare.com/]
#PharmaceuticalManufacturing #ContractManufacturing #HealthcareIndustry #PharmaInsights
Lotte Biologics Co. has secured a contract manufacturing deal with Rakuten Medical Inc. for a head and neck cancer drug, aiming to expand its global CMO presence and build a supply chain from clinical trials to commercialization.